Regional hyperthermia shows promise in treating high-risk soft tissue sarcomas

Regional hyperthermia (RHT) shows promise as an effective addition to multi-modal therapies for treating high-risk soft tissue sarcomas (STS), according to a study.

The systematic literature review found that when combined with perioperative chemotherapy or radiotherapy (RT)/neoadjuvant chemoradiotherap, RHT appeared to improve overall survival rates for patients with STS. The review also indicated that RHT was generally well-tolerated, with no significant reported toxicities.

However, to fully determine the optimal integration of RHT in STS treatment, further expert consensus and clinical trials are needed.

Reference
Veltsista PD, Oberacker E, Ademaj A, et al. Hyperthermia in the treatment of high-risk soft tissue sarcomas: a systematic review. Int J Hyperthermia. 2023;40(1):2236337. doi: 10.1080/02656736.2023.2236337. PMID: 37468132.